// App-Quantinova.ai

TCT-382 : Four-Year Outcomes with the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve: Results from the REPRISE II Study

Researchers

Presenter

  • David Hildick-Smith

Principal Investigators

  • Darren Walters

  • Nicolas Dumonteil

  • Stephen G. Worthley

  • Didier Tchetche

  • Ganesh Manoharan

  • Daniel Blackman

  • Gilles Rioufol

  • Robert Whitbourn

  • Thierry Lefevre

  • Ruediger Lange

  • Ralf Mueller

  • Simon Redwood

  • Dominic Allocco

  • Ian Meredith

Medical Centers

  • Clinique Pasteur, Toulouse, France

  • Royal Victoria Hospital, Belfast, United Kingdom

  • Cardiology Department, St. Vincent's Hospital Melbourne and Melbourne University, Melbourne, Victoria, Australia

  • Boston Scientific, Maple Grove, Minnesota, United States

  • Helios Kliniken, Siegburg, Germany

  • Hopital Cardiologique, Bron, France

  • Leeds General Infirmary, Leeds, United Kingdom

  • Genesis Healthcare, Sydney, Victoria, Australia

  • German Heart Center Munich, Munich, Germany

  • The Prince Charles Hospital, Chermside, Queensland, Australia

  • Ramsay Générale de Santé, Institut Cardiovasculaire Paris-Sud, Massy, France

  • St Thomas' Hospital, London, United Kingdom

  • Royal Sussex County Hospital, Brighton, United Kingdom

Locations

  • France

  • Australia

  • United Kingdom

  • Germany

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Aortic stenosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved